IPO - LogicMark, Inc.

Back to List of IPO Filings

Form Type: S-1MEF

Filing Date: 2025-02-14

Corporate Action: Ipo

Type: New

Accession Number: 000121390025014426

Filing Summary: LogicMark, Inc. filed a Registration Statement on Form S-1MEF with the SEC on February 14, 2025, under the Securities Act of 1933, to register additional securities for public offering. This follows a previous effective registration statement initially filed on January 3, 2025. The company is identified as a smaller reporting company and an emerging growth company. The additional securities to be offered represent no more than 20% of the maximum aggregate offering price from the earlier filing. The registration statement includes incorporated information from prior filings, legal opinions, and consents from auditors, and it was duly signed by the Chief Financial Officer and other authorized individuals on the date of filing.

Document Link: View Document

Additional details:

Approximate Date Of Commencement: As soon as practicable after this registration statement becomes effective


Additional Securities: amount and at a price that together represent no more than 20% of the maximum aggregate offering price


Prior Registration Statement: 333-284135


State Of Incorporation: Nevada


Irs Employer Identification Number: 46-0678374


Primary Sic Code: 7381


Address Of Registrant: 2801 Diode Lane, Louisville, KY 40299


Contact Phone Number: (502) 442-7911


Agent For Service: Mark Archer, Chief Financial Officer


Signatures: [{"name":"Mark Archer","title":"Chief Financial Officer"},{"name":"Chia-Lin Simmons","title":"Chief Executive Officer and Director"},{"date":"February 14, 2025"},{"name":"Carine Schneider","title":"Director"},{"name":"John Pettitt","title":"Director"},{"name":"Barbara Gutierrez","title":"Director"},{"name":"Robert Curtis","title":"Director"}]


Form Type: CORRESP

Filing Date: 2025-02-12

Corporate Action: Ipo

Type: New

Accession Number: 000121390025012884

Filing Summary: LogicMark, Inc. has submitted a request to the U.S. Securities and Exchange Commission to accelerate the effective date of their registration statement on Form S-1 to February 14, 2025, at 5:00 p.m. Eastern Time. This request is made under Rule 461 of the General Rules and Regulations of the Securities Act of 1933. The company acknowledges its responsibilities related to the proposed sale of securities once the registration statement is effective. They have provided contact information for their counsel for confirmation and have requested that a copy of the order verifying the effective date be sent to their counsel.

Document Link: View Document

Additional details:

Registration Statement File No: 333-284135


Counsel Name: Sullivan & Worcester LLP


Contact 1 Name: David Danovitch


Contact 1 Phone: (212) 660-3060


Contact 2 Name: Michael DeDonato


Contact 2 Phone: (212) 660-3038


Contact 3 Name: Hermione Krumm


Contact 3 Phone: (212) 660-3012


Email For Confirmation: [email protected]


Form Type: S-1/A

Filing Date: 2025-02-11

Corporate Action: Ipo

Type: Update

Accession Number: 000121390025012287

Filing Summary: LogicMark, Inc. is conducting an initial public offering (IPO) through the registration of up to 12,000,000 units, with each unit consisting of one share of Common Stock and two warrants. The offering is set at an assumed price of $1.00 per unit. The terms include provisions for pre-funded units for certain purchasers to avoid exceeding ownership thresholds. The prospectus outlines a focus on PERS technologies that leverage IoT for healthcare solutions, aiming to address aging population needs and a shift towards at-home care. The company has regained compliance with Nasdaq’s minimum price requirement and has been involved in recent reverse stock splits to improve share value. LogicMark engaged Roth Capital Partners as placement agent for this offering, which is contingent upon the receipt of investor funds. The document also mentions other compliance matters and internal developments as part of its growth strategy in the healthcare sector.

Document Link: View Document

Additional details:

Company Address: 2801 Diode Lane Louisville, KY 40299


Cfo Name: Mark Archer


Maximum Offering Amount: 12000000


Trading Symbol: LGMK


Previous Trading Price: 0.82


Reverse Stock Split Date: 2024-11-18


Form Type: S-1/A

Filing Date: 2025-02-07

Corporate Action: Ipo

Type: New

Accession Number: 000121390025011395

Filing Summary: LogicMark, Inc. is filing an amendment to their registration statement under the Securities Act of 1933 to offer up to 12,000,000 units, each unit consisting of one share of common stock and two warrants (Series C and Series D) to purchase additional shares of common stock at an assumed price of $1.00 per unit. The offering is being conducted on a best-efforts basis and will be executed upon the prospective sale completion. The company will also offer pre-funded units to limit ownership stakes for certain purchasers. LogicMark's Common Stock trades on Nasdaq under the symbol 'LGMK' and the company has engaged Roth Capital Partners as the exclusive placement agent for the offering. This follows a series of operational updates including compliance with Nasdaq listing requirements after a period of non-compliance in May 2024, due to the closure price of the stock. Furthermore, the company has undergone significant changes leading up to this offering, including a reverse stock split and an expansion strategy focusing on the growing market demand for personal emergency response systems (PERS) amidst demographic shifts and an increased reliance on at-home care technology. The offering aims to leverage emerging trends, specifically targeting the 'Silver Tsunami' of aging Baby Boomers and facilitating enhanced healthcare monitoring and response capabilities, positioning LogicMark for growth in services and product lines tailored for its customer base.

Document Link: View Document

Additional details:

Primary Offering Amount: 12000000


Unit Price: 1.00


Warrants Offered: series_c, series_d


Listing Exchange: Nasdaq


Common Stock Symbol: LGMK


Reverse Stock Split Date: 2024-11-18


Num Units Offered: up to 12000000


Proceeds Before Expenses: Not specified


Placement Agent: Roth Capital Partners, LLC


Use Of Proceeds: To expand market presence and improve product offerings in response to healthcare trends.


Form Type: CORRESP

Filing Date: 2025-01-31

Corporate Action: Ipo

Type: New

Accession Number: 000121390025008871

Filing Summary: LogicMark, Inc. has filed a request for the Securities and Exchange Commission to take action to make their registration statement on Form S-1/A effective by February 4, 2025. The statement relates to the initial public offering of the company's securities. Roth Capital Partners, as the underwriter, has distributed the Preliminary Prospectus dated January 21, 2025, to ensure adequate distribution. The letter indicates compliance with relevant rules and encourages the SEC to process their request promptly.

Document Link: View Document

Additional details:

Registration Statement File Number: 333-284135


Preliminary Prospectus Date: 2025-01-21


Contact Person Name: Ali Panjwani


Contact Person Phone: 212-326-0820


Underwriter Name: ROTH CAPITAL PARTNERS, LLC


Underwriter President: Aaron M. Gurewitz


Form Type: S-1/A

Filing Date: 2025-01-21

Corporate Action: Ipo

Type: New

Accession Number: 000121390025005012

Filing Summary: LogicMark, Inc. is registering for an initial public offering (IPO) of up to 3,472,222 units at an assumed offering price of $1.44 per unit, which includes one share of common stock and one common stock purchase warrant. Additionally, up to 3,472,222 pre-funded units, each consisting of one pre-funded warrant and one common stock purchase warrant, are available for purchase. The offering aims to raise capital to boost its personal emergency response systems (PERS) and related technologies. LogicMark focuses on the rapidly growing market demand for remote monitoring and care solutions, especially among aging populations. The company has recently regained compliance with Nasdaq listing requirements and has implemented a reverse stock split in November 2024 to maintain its share price. LogicMark has established a significant partnership with the U.S. Veterans Health Administration, enhancing its market position. The company aims to leverage ongoing trends in healthcare and technology to drive future growth and expand its customer base.

Document Link: View Document

Additional details:

State: Nevada


Primary Standard Industrial Classification Code Number: 7381


Irs Employer Identification Number: 46-0678374


Principal Executive Offices Address: 2801 Diode Lane, Louisville, KY 40299


Principal Executive Offices Phone: (502) 442-7911


Agent For Service Name: Mark Archer


Agent For Service Address: 2801 Diode Lane, Louisville, KY 40299


Agent For Service Phone: (502) 442-7911


Legal Counsel Firm: Sullivan & Worcester LLP


Legal Counsel Firm Address: 1251 Avenue of the Americas, New York, NY 10020


Legal Counsel Phone: (212) 660-3060


Emerging Growth Company: Yes


Minimum Bid Price Requirement Compliance: Yes


Placement Agent: Roth Capital Partners, LLC


Total Maximum Offering Amount: $5 million


Form Type: S-1

Filing Date: 2025-01-03

Corporate Action: Ipo

Type: New

Accession Number: 000121390025000848

Filing Summary: LogicMark, Inc., a company incorporated in Nevada, has filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission on January 3, 2025. The prospectus indicates that the company is offering up to a certain number of units, each consisting of one share of common stock and one common stock purchase warrant. Additionally, the company is offering pre-funded units for purchase that would result in ownership below a specified threshold. The offering follows a recent trend focusing on personal emergency response systems and addresses growing demand for connected care in home environments. The company outlines five key market trends including the aging population, shift to at-home care, and data integration through IoT technology which contribute to the large market opportunity for its products. Furthermore, LogicMark highlights recent corporate developments including regaining compliance with Nasdaq Listing Rule and the impact of a recent reverse stock split on their common stock. The expected delivery of the shares will occur electronically, with seamless transactions aimed at investor convenience. Overall, the document reflects LogicMark's strategy to enhance market presence and capitalize on emerging trends in health technology through the successful completion of the public offering.

Document Link: View Document

Additional details:

Company Address: 2801 Diode Lane, Louisville, KY 40299


Cfo Name: Mark Archer


Cfo Phone: (502) 442-7911


Agent Name: David E. Danovitch, Esq.


Agent Firm: Sullivan & Worcester LLP


Agent Firm Address: 1251 Avenue of the Americas, New York, NY 10020


Agent Phone: (212) 660-3060


Agent Name 2: M. Ali Panjwani, Esq.


Agent Firm 2: Pryor Cashman LLP


Agent Firm Address 2: 7 Times Square, New York, New York 10036


Agent Phone 2: (212) 421-4100


Maximum Offering Amount: [●]

Offering Price: $[●] per Unit

Warrant Exercise Price: $[●] per share

Units Offered: up to [●]


Form Type: 424B4

Filing Date: 2024-12-30

Corporate Action: Ipo

Type: New

Accession Number: 000121390024113244

Filing Summary: LogicMark, Inc. filed a prospectus pursuant to Rule 424(b)(4) for the offer and resale of up to 524,000 shares of common stock, which are issuable upon conversion of the Series H Preferred Stock. The prospectus details the settlement agreements made on November 13, 2024, with holders of Series B warrants, leading to the issuance of Series H Preferred Stock and newly designated Series I Preferred Stock. The Series H Conversion Shares will be resold by selling stockholders at market prices or negotiated prices, with no proceeds going to LogicMark from their sale. The company also carried out a one-for-twenty-five reverse stock split on November 18, 2024. The current trading price of LogicMark's common stock is noted at $1.68. The document outlines the investment risks, including potential future dilution from additional equity offerings.

Document Link: View Document

Additional details:

Series H Conversion Shares: 524,000


Settlement Agreements Date: 2024-11-13


Reverse Stock Split Date: 2024-11-18


Last Sales Price: 1.68


Comments

No comments yet. Be the first to comment!